Panel Discussion | The Last Remaining Issues Involving Radial Access

Saturday, March 8, 2025

9:25 AM – 9:45 AM ET

Panel Moderator(s)

Mazen S. Abu-Fadel, MD

Interventional Cardiology
Oklahoma Heart Hospital
Edmond, Oklahoma, United States

Disclosure(s): No financial relationships to disclose
Samir B. Pancholy, MD, MSCAI

Program Director, Fellowship in Cardiovascular Disease, Professor of Medicine
Wright Center of Graduate Medical Education, Geisinger Commonwealth School of Medicine, Scranton
Clarks Summit, Pennsylvania, United States

Disclosure(s): VasoInnovations Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Walter Tan, MD, MS

Associate Professor of Medicine
Wake Forest Univ - Atrium/Advocate/Baptist Health
Winston Salem, North Carolina, United States

Disclosure information not submitted.

Panel Discussant(s)

Amit Amin, MD

Associate Professor of Medicine
Rush University Medical Center
Chicago, Illinois, United States

Disclosure information not submitted.
Ronald P. Caputo, MD, MSCAI, FACC

Interventional Cardiologist, Director of Cardiovascular Services
PHysician's Regional Medical Center Naples FL
Naples, Florida, United States

Disclosure(s): Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Transradial Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Richard Casazza, MAS

Special procedures technologist
Maimonides medical center
Staten Island, New York, United States

Disclosure(s): Tesslagra Design Solutions llc: Employee (Ongoing)
Michael A. Gaglia, Jr., MD, MSc, FACC, FSCAI

Interventional Cardiologist
St. Clair Hospital
Bethel Park, Pennsylvania, United States

Disclosure information not submitted.
Ian C. Gilchrist, Sr., MD, MSCAI

Professor Of Medicine
Penn State University/Hershey Medical Center
Hummelstown, Pennsylvania, United States

Disclosure(s): No financial relationships to disclose
Edo Kaluski, MD, FSCAI

Director of Cath Lab & Interventional Cardiology
Robert Packer Hospital Guthrie Health Systems
Sayre, Pennsylvania, United States

Disclosure(s): No financial relationships to disclose
Jonathan Roberts, MD

Medical Director, Interventional Cardiology Research and Education Program Director, Cardiology Fellowship
Memorial Healthcare System
Hollywood, Florida, United States

Disclosure information not submitted.
Arnold H. Seto, MD, MPA

Director of Cardiac Cath Lab
Long Beach Veterans Affairs Medical Center
Long Beach, California, United States

Disclosure(s): Frond Medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); GE Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Maquet Getinge Group: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Summacor: Consultant (Ongoing), Stock-privately held company (Ongoing)
Koki Shishido, MD

Director of Cardiology
Shonan Kamakura General Hospital
Kamakura, Japan

Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Craig M. Walker, MD

Chief Medical Director/President/Founder
Cardiovascular Institute of the South
Gray, Louisiana, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Mazen S. Abu-Fadel, MD: No financial relationships to disclose

Samir B. Pancholy, MD, MSCAI: VasoInnovations Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Ronald P. Caputo, MD, MSCAI, FACC: Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Transradial Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Richard Casazza, MAS: Tesslagra Design Solutions llc: Employee (Ongoing)

Ian C. Gilchrist, MD, MSCAI, Sr.: No financial relationships to disclose

Edo Kaluski, MD, FSCAI: No financial relationships to disclose

Arnold H. Seto, MD, MPA: Frond Medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); GE Healthcare: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Maquet Getinge Group: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Summacor: Consultant (Ongoing), Stock-privately held company (Ongoing)

Koki Shishido, MD: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Craig M. Walker, MD: No financial relationships to disclose